標(biāo)題: Titlebook: Biotechnologies for Gene Therapy; RNA, CRISPR, Nanobot Yang H. Yun,Kristine E. Yoder Book 2022 The Editor(s) (if applicable) and The Author [打印本頁] 作者: FETID 時(shí)間: 2025-3-21 19:05
書目名稱Biotechnologies for Gene Therapy影響因子(影響力)
書目名稱Biotechnologies for Gene Therapy影響因子(影響力)學(xué)科排名
書目名稱Biotechnologies for Gene Therapy網(wǎng)絡(luò)公開度
書目名稱Biotechnologies for Gene Therapy網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Biotechnologies for Gene Therapy被引頻次
書目名稱Biotechnologies for Gene Therapy被引頻次學(xué)科排名
書目名稱Biotechnologies for Gene Therapy年度引用
書目名稱Biotechnologies for Gene Therapy年度引用學(xué)科排名
書目名稱Biotechnologies for Gene Therapy讀者反饋
書目名稱Biotechnologies for Gene Therapy讀者反饋學(xué)科排名
作者: 善變 時(shí)間: 2025-3-21 22:06
http://image.papertrans.cn/b/image/188684.jpg作者: Vldl379 時(shí)間: 2025-3-22 03:37
https://doi.org/10.1007/978-3-030-93333-3DNA nanobots; CRISPR gene therapy; microRNA gene therapy; DNA gene therapy; delivery microRNA; clinical a作者: biopsy 時(shí)間: 2025-3-22 06:36
978-3-030-93335-7The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl作者: GLUE 時(shí)間: 2025-3-22 09:03 作者: Expiration 時(shí)間: 2025-3-22 13:02 作者: COST 時(shí)間: 2025-3-22 18:39 作者: Ibd810 時(shí)間: 2025-3-22 23:47
Blutungen nach Massivtransfusione regulatory area of the gene in the chromatin, the promoter. There are various ways by which gene expression activation can occur. In the end, epigenetic marks are modified in the promoter, for example, silencing modifications such as trimethylation of histone3 lysine 27 are reduced, and activating作者: Angioplasty 時(shí)間: 2025-3-23 02:36
https://doi.org/10.1007/978-3-662-12220-4 of dystrophin disrupts the skeletal musculature, resulting in severe muscle degeneration. Currently, the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) system offers an evolved and precise tool of programmed genomic modification and is being widely studie作者: 1分開 時(shí)間: 2025-3-23 06:27
Die Heparin-induzierte Thrombozytopenie caused by the human immunodeficiency (HIV) or the hepatitis B and C viruses (HBV and HCV) and the emergence of a variety of “new” viruses including SARS-CoV-2. The pharmaceutical industry and the scientific community work on the development of new antiviral drugs, including the repurposing of previ作者: 創(chuàng)造性 時(shí)間: 2025-3-23 12:33
https://doi.org/10.1007/978-3-642-72405-3e agent of adult T-cell leukemia/lymphoma (ATL), the immune-mediated neurodegenerative disease, HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), and a number of other inflammatory disorders. These HTLV-1-related diseases develop in a portion of infected individuals after a prolon作者: 疏遠(yuǎn)天際 時(shí)間: 2025-3-23 15:29
https://doi.org/10.1007/978-3-7091-4738-2cells. In addition, retroviruses do not activate the immune system, allowing for multiple doses with the same viral vector. Retroviral vectors are also readily pseudotyped expanding their tropism to a variety of cell types. In spite of these advantages, gene therapy trials with gammaretrovirus murin作者: PON 時(shí)間: 2025-3-23 19:31
https://doi.org/10.1007/978-3-7091-4738-2uctures combine several advantages, which make them well suited for numerous biomedical applications. Particular advantages of DNA nanostructures include unprecedented control over nanoscale geometry and precise functionalization with molecules including small molecule therapeutics, nucleic acids (e作者: 向前變橢圓 時(shí)間: 2025-3-24 00:22 作者: capsule 時(shí)間: 2025-3-24 03:21 作者: 不要不誠實(shí) 時(shí)間: 2025-3-24 08:35
Small Activating RNA Therapy for Angiogenesis,so become available for increasing gene expression. However, small RNAs have an advantage over longer RNAs for some purposes, such as cardiovascular gene therapy, as they are much more stable and induce fewer immunological responses. Vascular endothelial growth factor A, a key regulator of angiogene作者: 尖酸一點(diǎn) 時(shí)間: 2025-3-24 14:41
Muscular Dystrophy Therapy Using Viral Vector-based CRISPR/Cas,PR/Cas components. Efforts have been made to optimize the viral vector systems for efficient delivery of these components to treat DMD. Herein, we review diverse aspects of several viral vectors combined with CRISPR/Cas systems for DMD therapy and discuss their therapeutic potential and the challeng作者: 懶惰民族 時(shí)間: 2025-3-24 16:12 作者: 脫水 時(shí)間: 2025-3-24 19:06 作者: Coma704 時(shí)間: 2025-3-24 23:55
DNA Origami Nanodevices for Therapeutic Delivery Applications,n processes; briefly describe nonclinical applications; and focus on preclinical development of DNA nanostructures as drug delivery devices with an emphasis on nanostructures engineered via the DNA origami fabrication method.作者: intelligible 時(shí)間: 2025-3-25 04:25
Viola Hach-Wunderle,Peter P. Nawrothategy for liver fibrosis. With recent advances in our understanding of nanomedicines, nanoparticles are regarded as promising candidates for efficient delivery methods for miRNAs because of their biological and technical advantages. In this chapter, we review the pathogenesis of liver fibrosis, the 作者: 系列 時(shí)間: 2025-3-25 09:13
Blutungen in der Transplantationschirurgielicated in the regulation of normal cell physiology. Additionally, miRNAs influence numerous cancer-relevant processes, such as cell proliferation, stemness, epithelial-to-mesenchymal transition, and migration, and can act as either oncogenes or tumor suppressors. In agreement with this, many types 作者: evince 時(shí)間: 2025-3-25 12:56 作者: phlegm 時(shí)間: 2025-3-25 16:34
https://doi.org/10.1007/978-3-662-12220-4PR/Cas components. Efforts have been made to optimize the viral vector systems for efficient delivery of these components to treat DMD. Herein, we review diverse aspects of several viral vectors combined with CRISPR/Cas systems for DMD therapy and discuss their therapeutic potential and the challeng作者: 火光在搖曳 時(shí)間: 2025-3-25 22:07
Die Heparin-induzierte Thrombozytopeniection on the CRISPR-Cas technology, we will explore the advantages and limitations of this antiviral approach and discuss the future prospects for improvement of diagnostics and therapeutics and their potential for future clinical application.作者: Pituitary-Gland 時(shí)間: 2025-3-26 03:48 作者: Negotiate 時(shí)間: 2025-3-26 05:31 作者: 下邊深陷 時(shí)間: 2025-3-26 11:37 作者: 無脊椎 時(shí)間: 2025-3-26 14:21
Book 2022to cardiovascular and degenerative disorders. It also features innovations of the delivery methods for nucleic acids ranging from nanodevices made from DNA and pseudo amino acids to viral vectors.?This is an ideal book for academics, clinicians, and students interested in gene therapy..作者: epidermis 時(shí)間: 2025-3-26 19:20
ethods and techniques for preclinical applications of miroRN.The purpose of this book is to highlight some of latest developments and applications of CRISPR, RNA, and DNA to treat diseases ranging from cancers to cardiovascular and degenerative disorders. It also features innovations of the delivery作者: eczema 時(shí)間: 2025-3-26 21:43 作者: 發(fā)生 時(shí)間: 2025-3-27 03:23 作者: 殘暴 時(shí)間: 2025-3-27 06:29 作者: 克制 時(shí)間: 2025-3-27 10:41 作者: Cardioplegia 時(shí)間: 2025-3-27 14:12
Small Activating RNA Therapy for Angiogenesis,e regulatory area of the gene in the chromatin, the promoter. There are various ways by which gene expression activation can occur. In the end, epigenetic marks are modified in the promoter, for example, silencing modifications such as trimethylation of histone3 lysine 27 are reduced, and activating作者: 植物茂盛 時(shí)間: 2025-3-27 21:05
Muscular Dystrophy Therapy Using Viral Vector-based CRISPR/Cas, of dystrophin disrupts the skeletal musculature, resulting in severe muscle degeneration. Currently, the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) system offers an evolved and precise tool of programmed genomic modification and is being widely studie作者: 供過于求 時(shí)間: 2025-3-27 23:45 作者: amorphous 時(shí)間: 2025-3-28 05:48 作者: Cupping 時(shí)間: 2025-3-28 10:09
Retroviral Vectors for Gene Therapy of Monogenic Diseases,cells. In addition, retroviruses do not activate the immune system, allowing for multiple doses with the same viral vector. Retroviral vectors are also readily pseudotyped expanding their tropism to a variety of cell types. In spite of these advantages, gene therapy trials with gammaretrovirus murin作者: 火花 時(shí)間: 2025-3-28 11:51 作者: IRK 時(shí)間: 2025-3-28 18:32
Cyberspace Endogenous Security and Safety Problems,iety, cyberspace security and safety problems have become a lingering specter, threatening the basic order and rules of the digital world at all times, and trampling on the common values and codes of conduct of the human society without any bottom line. In uneasy anxiety and unintelligible fear, peo
